Cargando…
Procalcitonin as a biomarker of infectious diseases
Traditional biomarkers, including C-reactive protein, leukocytes, erythrocyte sedimentation rate, and clinical signs and symptoms, are not sufficiently sensitive or specific enough to guide treatment decisions in infectious febrile diseases. Procalcitonin (PCT) is synthesized by a large number of ti...
Autor principal: | Lee, Hyuck |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654123/ https://www.ncbi.nlm.nih.gov/pubmed/23682219 http://dx.doi.org/10.3904/kjim.2013.28.3.285 |
Ejemplares similares
-
Biomarkers in Pneumonia—Beyond Procalcitonin
por: Karakioulaki, Meropi, et al.
Publicado: (2019) -
Procalcitonin in respiratory disease: use as a biomarker for diagnosis and guiding antibiotic therapy
por: Creamer, Andrew W., et al.
Publicado: (2019) -
Procalcitonin as an adjunctive biomarker in sepsis
por: Sinha, Mahua, et al.
Publicado: (2011) -
Procalcitonin as an Endogenous Biomarker for Mastitis in Cows
por: Neumann, Stephan, et al.
Publicado: (2023) -
Serum Procalcitonin and Procalcitonin Clearance as a Prognostic Biomarker in Patients with Severe Sepsis and Septic Shock
por: Huang, Min-Yi, et al.
Publicado: (2016)